undefined undefined
NaN.000
NaN.00%
加拿大投资银行集团:维持Fate Therapeutics(FATE.US)评级,由买入调整至买入评级, 目标价由11.00美元调整至9.00美元。
05-11 02:41
The latest announcement is out from Fate Therapeutics (FATE). Fate Therapeutics...
05-09 21:12
Wedbush analyst David Nierengarten maintained a Hold rating on Fate Therapeutic...
05-06 19:55
The name-sharing duo huddled to honor the Motor City by giving back and honorin...
04-24 21:30
Needham analyst Gil Blum reiterates Fate Therapeutics (NASDAQ:FATE) with a Hold.
04-11 18:09
Gainers: Stoke Therapeutics (STOK) +87%. AnaptysBio (ANAB) +8%. Amneal Pharmaceuticals (AMRX) +6%. Omega Therapeutics (OMGA) +5%. MoneyHero (MNY) +5%. Losers: Ocular Therapeutix (OCUL) -6%. Fate Ther...
03-26 05:15
5 analysts have expressed a variety of opinions on Fate Therapeutics (NASDAQ:FA...
03-19 20:00
It's been a good week for Fate Therapeutics, Inc. (NASDAQ:FATE) shareholders, b...
02-29 06:35
In the latest quarter, 4 analysts provided ratings for Fate Therapeutics (NASDA...
02-28 04:00